Menu

Microscopy Tool Can “See” Through Dense Tissue: Study

Scientists tout this lens-free holographic technique as a cost-effective alternative to standard tissue biopsies. 

Aug 11, 2017
Aggie Mika

Lens-free holographic microscopy (left) and scanning optical microscope (right) of a 200-micron thick mouse brain sampleZHANG ET AL., SCI ADV, 3:E1700553, 2017. A novel imaging technique allows researchers to peer through thick, three-dimensional tissues using a holographic microscope and economical, easily transported tools, according to a study published today (August 11) in Science Advances. The tissue preparation and imaging protocol is meant to serve as an alternative to costlier techniques that aren’t easily accessible in resource-starved areas.

The researchers demonstrated the utility of their technique on a slice of a mouse brain, 200 microns (0.2 millimeters) in thickness. First, they made their tissue sample see-through using a tweaked version of the CLARITY tissue-clearing method, which removes lipids within tissue, then applied a stain to visualize brain cells. The researchers placed their sample near an image-sensing chip, which digitally acquired a focused, 3-D image. Traditional techniques, on the other hand, require lenses and cumbersome optical apparatuses.  

See “Next Generation: See-through Mice

See “Scientists Create See-Through Hearts

They verified their reconstructed images by comparing them to those obtained by a scanning optical microscope. This test confirmed that the lens-free technique can be used to create a more-focused image.

“We believe that this CLARITY-enabled computational tissue imaging technique could find numerous applications in biomedical diagnosis and research in low-resource settings,” the authors write.

Diagnosing diseases that leave their mark on the body’s tissues, like cancer, often requires tissue biopsies. But the tools and expertise required to process such tissues can be expensive and is not widely available, especially in developing areas. “The high cost of equipment and the lack of trained health care professionals may result in delays in diagnosis,” the authors write in their report. 

Depiction of the lens-free imaging set up OZCAN RESEARCH GROUP AT UCLA

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.